Discover open access scientific publications

A Combination of Pharmacophore Modeling, Molecular Docking and Virtual Screening Study Reveals 3,5,7-Trihydroxy-2-(3,4,5-Trihydroxyphenyl)- 4h-Chromen-4-One as a Potential Anti-Cancer Agent of COT Kinase